Skip to main content

Table 1 Demographic data and drug history of each of 14 patients taking Vigabatrin

From: Relationship between the area of isopters and Vigabatrin dosage during two years of observation

No

Age

Gender

Visual acuity

Mean daily dose of VGB (mg)

Cumulative dose of VGB (g)

Duration of VGB treatment (months)

Duration of follow-up (months)

Other antiepileptic drugs

Classification of the SKP visual field

Right

Left

1

54

M

1.0

0.9

1800

1470

27

25

OCZ

Normal

2

23

F

1.0

1.0

1450

1050

24

24

VPA, LTG

Normal

3

41

F

1.0

1.0

1000

1230

21

24

OCZ

Mildly abnormal

4

53

F

1.0

1.0

1000

750

23

25

VPA

Normal

5

48

F

1.0

1.0

1500

1305

29

24

CBZ, CLZ

Normal

6

34

M

1.0

1.0

2100

1440

23

23

VPA, CBZ

Normal

7

27

M

1.0

1.0

1900

1710

29

25

VPA, CBZ

Normal

8

56

F

1.0

1.0

1000

1290

27

21

CBZ

Normal

9

59

M

0.7

1.0

2300

1365

24

24

VPA

Mildly abnormal

10

49

F

1.0

1.0

2000

1740

24

21

CBZ

Normal

11

48

M

1.0

1.0

1500

11305

24

22

CBZ

Normal

12

31

F

1.0

1.0

1000

300

11

14

CBZ

Normal

13

39

F

1.0

1.0

1000

6000

15

12

CBZ

Normal

14

35

M

1.0

1.0

1000

750

25

25

CBZ

Normal

  1. F-female, M-male.
  2. VGB-Vigabatrin.
  3. mg-miligram.
  4. g-gram.
  5. CBZ – carbamazepin.
  6. CLZ – clonazepam.
  7. OCZ – oxcarbazepin.
  8. VPA- valproate.
  9. LTG-lamotrigine.
  10. TGB-tiagabine.
  11. TPM-topiramate.
  12. SKP-semi-automated kinetic perimetry.